Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
2019 · Nature Medicine · 395 citations
https://doi.org/10.1038/s41591-019-0400-z
B
Bernhard Gentner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
183
Papers
6.6K
Citations
34
h-index
63
i10-index
Bernhard Gentner is an academic researcher from University Hospital of Lausanne. The author has contributed to research in topics: Virus-based gene therapy research & RNA Interference and Gene Delivery & CAR-T cell therapy research. The author has an h-index of 34, co-authored 156 publications.
ORCID: 0000-0001-6024-4718Papers by this author
worksmiR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells
2016 · Cancer Cell · 259 citations
https://doi.org/10.1016/j.ccell.2015.12.011
Long-term lineage commitment in haematopoietic stem cell gene therapy
2024 · Nature · 37 citations
https://doi.org/10.1038/s41586-024-08250-x
A Double-Switch Vector System Positively Regulates Transgene Expression by Endogenous microRNA Expression (miR-ON Vector)
2013 · Molecular Therapy · 34 citations
https://doi.org/10.1038/mt.2013.12
Genetic Testing for Germline Mutations of the APC Gene in Patients With Apparently Sporadic Desmoid Tumors but a Family History of Colorectal Carcinoma
2005 · Diseases of the Colon & Rectum · 33 citations
https://doi.org/10.1007/s10350-004-0949-5
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID
2024 · Nature Communications · 26 citations
https://doi.org/10.1038/s41467-024-47866-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat